Managing Persistence Problems -Starting and Stopping GLP-1 Medications
Most people don’t like taking medications – especially longterm. In fact, medication fatigue where individuals stop taking a new medication, like a statin or blood pressure pill, is commonplace. But...
Can Treating Obesity Improve Women’s Health and Fertility?
I recently had the exciting opportunity to educate gynecologists and fertility specialists throughout India on the role of semaglutide in women’s reproductive health. This allowed me to take a deep...
‘Treat to Target’ Considerations in Obesity Care
As the field of obesity medicine matures, clinicians and patients are asking: “What is the treatment target?” achievement of a targeted percentage weight loss? improved body mass index (BMI) or...
Ripple Effects of GLP-1 Obesity Medications on Society
The effects of game-changing GLP-1 medications on individuals and society was the topic of my recent keynote address at the Northwestern University Alumni Association event in Naples, Florida. Individuals on...
New Standards of Care Offer Proactive Approach to Prescribing Obesity Medications
With the advent of powerful obesity medications that address the biological basis of obesity, the field of obesity care is rapidly shifting. To reflect this, the first Standards of Care...
Team-Based Obesity Care – in the Era of Highly Effective Medications
Obesity care is a team sport. One clinician does not have to shoulder all the responsibility nor is expected to have the necessary expertise in all aspects of care. And...
Empathy Goes Both Ways in Obesity Care
I enjoy speaking to healthcare professionals helping them identify efficient and effective approaches to patient-centered obesity care. One of the most interesting questions I received recently from physicians is how...
When Life Gets in the Way – of Managing Weight
Before I help patients develop a personalized weight management plan, I want to better understand each person’s weight journey, that is, how they got to where they are today. Since...
